4Accepted Sep 8, 4:30 PM ET
Phathom (PHAT) Robert Breedlove Surrenders 460 Shares for Tax Withholding
Accepted (ET)
4:30 PM
Sep 8, 2026
Filed
Sep 8, 2026
Documents
1
Size
5.6 KB
Summary
Phathom (PHAT) Robert Breedlove Surrenders 460 Shares for Tax Withholding
What Happened
- Robert Charles Breedlove, Principal Accounting Officer at Phathom Pharmaceuticals (PHAT), surrendered 460 shares underlying restricted stock units to satisfy the issuer’s tax withholding obligation. The shares were valued at $9.05 each, totaling $4,163. This was a tax-withholding disposition rather than an open-market sale.
Key Details
- Transaction date: 2026-09-03 (report filed 2026-09-08)
- Price per share: $9.05; shares surrendered/disposed: 460; total value: $4,163
- Shares owned after transaction: not specified in the provided filing
- Footnote: F1 indicates these were RSU shares surrendered to the issuer to satisfy tax withholding
- Filing timeliness: transaction reported on a Form 4 filed Sep 8 for a Sep 3 transaction (no late-filing flag provided in the supplied data)
Context
- This was a common cashless/tax-withholding action where an insider surrenders vested RSU shares to cover taxes; it is routine and does not necessarily reflect a view on the company’s prospects. It is different from an open-market sale, which would represent a transfer of shares to other investors.